Research map: Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study

Back to the article

Papers in this map

  1. Sex differences in pain: a brief review of clinical and experimental findings · Emily J. Bartley · 2013 · 2186 citations · Cited by this paper
  2. Comparative characteristics and outcomes of bacterial and fungal skull base osteomyelitis: a retrospective analysis of 127 cases · 2026 · Related
  3. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa · Anita Petra Hardon · 2007 · 507 citations · Cited by this paper
  4. A tiered molecular surveillance framework linking rapid dengue detection to genomic epidemiology in Senegal · 2026 · Related
  5. A Systematic Review of Individual and Contextual Factors Affecting ART Initiation, Adherence, and Retention for HIV-Infected Pregnant and Postpartum Women · Ian J Hodgson · 2014 · 309 citations · Cited by this paper
  6. Screening for tuberculosis in prisons: efficacy of a breath-based diagnostic approach in a high prevalence setting · 2026 · Related
  7. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel · Rajesh Tim Gandhi · 2024 · 267 citations · Cited by this paper
  8. Identifying emergency department patients at risk of diagnostic discordance between the presumptive emergency department diagnosis and the adjudicated discharge diagnosis: the independent role of frailty · 2026 · Related
  9. Adherence to HIV treatment regimens: systematic literature review and meta-analysis · Frederick Lewis Altice · 2019 · 242 citations · Cited by this paper
  10. Age Specific Hospitalization Dynamics During a Measles Outbreak in Nyanza District, Southern Province, Rwanda, 2026: A Survival Analysis with Implications for Clinical Management · 2026 · Related
  11. Factors Influencing Medication Adherence Beliefs and Self-Efficacy in Persons Naive to Antiretroviral Therapy: A Multicenter, Cross-Sectional Study · Nancy R. Reynolds · 2004 · 205 citations · Cited by this paper
  12. Identifying rate-limiting steps in the antimicrobial workflow for community-onset sepsis · 2026 · Related
  13. A Systematic Review of Health System Barriers and Enablers for Antiretroviral Therapy (ART) for HIV-Infected Pregnant and Postpartum Women · Christopher James Colvin · 2014 · 147 citations · Cited by this paper
  14. Prevalence of Enterovirus genus respiratory infections and co-infections: a cross-sectional study in a Northeast Italian Hospital (2023-2025) · 2026 · Related
  15. Long-acting antiretrovirals and HIV treatment adherence · Jean Bisimwa Nachega · 2023 · 145 citations · Cited by this paper
  16. Lytic bacteriophages active in urine against multi-drug resistant clinically derived Klebsiella pneumoniae causing urinary tract infection · 2026 · Related
  17. Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study · Edgar Turner Overton · 2023 · 142 citations · Cited by this paper
  18. Broadly cross-reactive neutralizing and enhancing antibody responses to dengue, Japanese encephalitis viruses and Zika in sera from Vietnamese pediatric dengue cases. · 2026 · Related
  19. Barriers to antiretroviral medication adherence in HIV-infected women · Kathleen Johnston Roberts · 2000 · 137 citations · Cited by this paper
  20. High Prevalence and Territorial Heterogeneity of Intestinal Parasite Detection in Ecuador: A Large Registry-Based Cross-Sectional Study Using Routine Stool Examinations · 2026 · Related
  21. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare · Christine Tapp · 2011 · 125 citations · Cited by this paper
  22. Gender differences in the treatment of HIV infection · Marco Floridia · 2008 · 99 citations · Cited by this paper
  23. A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases · Andreea Catalina Brabete · 2022 · 80 citations · Cited by this paper
  24. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality · Tracy R. Glass · 2015 · 76 citations · Cited by this paper
  25. Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy · Morgan Mari Philbin · 2020 · 75 citations · Cited by this paper
  26. Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy · Palmira de Fátima Bonolo · 2013 · 52 citations · Cited by this paper
  27. The adherence gap · Cathy M. Puskas · 2017 · 38 citations · Cited by this paper
  28. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges · Aadia I. Rana · 2026 · 34 citations · Cited by this paper
  29. Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort · Roberta Gagliardini · 2025 · 19 citations · Cited by this paper
  30. Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV · Kyle Ring · 2025 · 15 citations · Cited by this paper
  31. Oral antiretroviral adherence interventions in the era of U=U · Claire Keene · 2025 · 8 citations · Cited by this paper
  32. Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead · Luís Buzón · 2025 · 6 citations · Cited by this paper
  33. Real-world efficacy and tolerability of CAB+RPV LA in women: addressing the gender gap in HIV treatment research · Marta Rosas Cancio-Suárez · 2025 · 4 citations · Cited by this paper
  34. Exploring the Interaction Between Injection Site and Biological Sex on the Real-world Population Pharmacokinetics of Long-acting Cabotegravir and Rilpivirine in People With HIV · Benedict Tan · 2025 · 2 citations · Cited by this paper
  35. Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy · Tali Faggiano · 2025 · 2 citations · Cited by this paper
  36. Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort · Jesús Troya · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)